IS2147B - Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju - Google Patents

Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju

Info

Publication number
IS2147B
IS2147B IS5505A IS5505A IS2147B IS 2147 B IS2147 B IS 2147B IS 5505 A IS5505 A IS 5505A IS 5505 A IS5505 A IS 5505A IS 2147 B IS2147 B IS 2147B
Authority
IS
Iceland
Prior art keywords
diol
alpha
mixture
hydroxyacid
hyperplasia
Prior art date
Application number
IS5505A
Other languages
English (en)
Other versions
IS5505A (is
Inventor
Gånemo Agneta
Original Assignee
Astellas Pharma Europe B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Europe B.V. filed Critical Astellas Pharma Europe B.V.
Publication of IS5505A publication Critical patent/IS5505A/is
Publication of IS2147B publication Critical patent/IS2147B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5505A 1997-11-25 2000-05-23 Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju IS2147B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (en) 1997-11-25 1998-11-25 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Publications (2)

Publication Number Publication Date
IS5505A IS5505A (is) 2000-05-23
IS2147B true IS2147B (is) 2006-09-15

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5505A IS2147B (is) 1997-11-25 2000-05-23 Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju

Country Status (22)

Country Link
US (1) US6399082B1 (is)
EP (1) EP1032378B1 (is)
CN (1) CN1140266C (is)
AT (1) ATE213939T1 (is)
AU (1) AU754420B2 (is)
BG (1) BG64743B1 (is)
BR (1) BR9815016A (is)
CA (1) CA2310049C (is)
CZ (1) CZ290165B6 (is)
DE (1) DE69804130T2 (is)
DK (1) DK1032378T3 (is)
ES (1) ES2174533T3 (is)
HK (1) HK1034194A1 (is)
HU (1) HU226065B1 (is)
IS (1) IS2147B (is)
NO (1) NO320100B1 (is)
NZ (1) NZ504458A (is)
PL (1) PL190023B1 (is)
PT (1) PT1032378E (is)
SK (1) SK284505B6 (is)
TR (1) TR200001486T2 (is)
WO (1) WO1999026617A1 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
EP1080226A4 (en) * 1998-05-21 2004-04-21 Isis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF OLIGONUCLEOTIDES
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
US20030017181A1 (en) 2001-05-31 2003-01-23 Rood Gloria A. Dermatological compositions and methods
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
EP1996021B1 (en) 2006-02-28 2017-12-13 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20110021618A1 (en) * 2008-03-25 2011-01-27 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2404156T3 (es) * 2009-04-13 2013-05-24 Vanangamudi Subramaniam SULUR Una crema medicinal con ácido fusídico hecha utilizando fusidato de sodio e incorporando un biopolímero y el proceso para hacerla
EP2429559A4 (en) * 2009-05-08 2013-08-14 Allmedic Pty Ltd TREATMENT OF PAIN AND / OR INFLAMMATION AS WELL AS TREATMENT AND PREVENTION OF SKIN OR SLICING DISEASES OR TROUBLES
CN107308163A (zh) * 2010-11-04 2017-11-03 442合资有限责任公司 用于治疗皮肤病的组合物和方法
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
WO1995007688A1 (en) * 1993-09-15 1995-03-23 Unilever Plc Skin care method and composition

Also Published As

Publication number Publication date
SK7432000A3 (en) 2001-05-10
HU226065B1 (hu) 2008-04-28
IS5505A (is) 2000-05-23
US6399082B1 (en) 2002-06-04
EP1032378B1 (en) 2002-03-06
EP1032378A1 (en) 2000-09-06
ATE213939T1 (de) 2002-03-15
AU1965999A (en) 1999-06-15
CZ20001920A3 (cs) 2001-04-11
WO1999026617A1 (en) 1999-06-03
DK1032378T3 (da) 2002-04-15
CZ290165B6 (cs) 2002-06-12
NO20002649D0 (no) 2000-05-24
HK1034194A1 (en) 2001-10-19
CA2310049A1 (en) 1999-06-03
NO320100B1 (no) 2005-10-24
DE69804130T2 (de) 2002-07-25
ES2174533T3 (es) 2002-11-01
PT1032378E (pt) 2002-07-31
CN1280495A (zh) 2001-01-17
CN1140266C (zh) 2004-03-03
SK284505B6 (sk) 2005-05-05
BG104470A (en) 2001-03-30
NZ504458A (en) 2002-03-01
PL190023B1 (pl) 2005-10-31
BR9815016A (pt) 2000-10-03
BG64743B1 (bg) 2006-02-28
NO20002649L (no) 2000-07-24
CA2310049C (en) 2008-02-19
TR200001486T2 (tr) 2001-07-23
PL340679A1 (en) 2001-02-12
HUP0100066A2 (hu) 2001-08-28
AU754420B2 (en) 2002-11-14
DE69804130D1 (de) 2002-04-11
HUP0100066A3 (en) 2006-07-28

Similar Documents

Publication Publication Date Title
IS2147B (is) Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
NZ335981A (en) Ketobenzamides as calpain inhibitors
NO20020299D0 (no) Behandling og sammensetning for oppnåelse av antialdring av hud med Corneum Protease aktivering
ATE209483T1 (de) Behandlung von multipler sklerose
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
NO994330D0 (no) Metode for behandling av en tumor
PT1390007E (pt) Composição cosmética à base de sucralfato e de sulfatos de cobre e de zinco
HK1048308A1 (en) Novel compounds.
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
ZA9711468B (en) New use of comt inhibitors
MXPA99007442A (es) Composiciones retinoides topicas y de serinaproteasa.
DE69637416D1 (de) Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen
GEU1997305Y (en) Means Having Wound Healing Activity
UA15479A (uk) Мазь для лікуваhhя епідермофітії та спосіб лікуваhhя епідермофітії
UA885A1 (uk) Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї